Ambeed.cn

首页 / / / 表观遗传阅读框 / MS402

MS402 {[allProObj[0].p_purity_real_show]}

货号:A1177083 Ambeed 开学季,买赠积分,赢豪礼

MS402 is a domain-selective inhibitor of BRD4-BD1 with Ki value of 77nM, over BRD4-BD2.

MS402 化学结构 CAS号:1672684-68-2
MS402 化学结构
CAS号:1672684-68-2
MS402 3D分子结构
CAS号:1672684-68-2
MS402 化学结构 CAS号:1672684-68-2
MS402 3D分子结构 CAS号:1672684-68-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

MS402 纯度/质量文件 产品仅供科研

货号:A1177083 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 BET bromodomain BRPF CBP/beta-catenin p300/CBP 其他靶点 纯度
MS436 ++

BRD4 (2), Ki: 0.34 μM

BRD4 (1), Ki: <0.085 μM

{[allProObj[0].p_purity_real_show]}
CPI-203 +++

BRD4, IC50: 37 nM

{[allProObj[0].p_purity_real_show]}
GSK1324726A +++

BRD2, IC50: 31 nM

BRD4, IC50: 22 nM

{[allProObj[0].p_purity_real_show]}
PFI-1 ++

BRD2, IC50: 98 nM

BRD4, IC50: 0.22 μM

{[allProObj[0].p_purity_real_show]}
Apabetalone +

BD2, IC50: 0.51 μM

{[allProObj[0].p_purity_real_show]}
(+)-JQ1 +++

BRD4 (1), IC50: 77 nM

BRD4 (2), IC50: 33 nM

{[allProObj[0].p_purity_real_show]}
I-BET151 +

BRD3, IC50: 0.25 μM

BRD4, IC50: 0.5 μM

{[allProObj[0].p_purity_real_show]}
Molibresib +++

BET proteins, IC50: 35 nM

{[allProObj[0].p_purity_real_show]}
I-BRD9 +++

BRD9, pIC50: 7.3

BRD4, pIC50: 5.3

{[allProObj[0].p_purity_real_show]}
BI-7273 ++++

BRD7, IC50: 117 nM

BRD9, IC50: 19 nM

{[allProObj[0].p_purity_real_show]}
Pelabresib +++

BRD4-BD1, IC50: 39 nM

{[allProObj[0].p_purity_real_show]}
ARV-825 +++

BRD4 BD2, Kd: 28 nM

BRD4 BD1, Kd: 90 nM

{[allProObj[0].p_purity_real_show]}
Birabresib {[allProObj[0].p_purity_real_show]}
BI 2536 +++

BRD4, Kd: 37 nM

c-Myc {[allProObj[0].p_purity_real_show]}
Bromosporine ++

BRD2, IC50: 0.29 μM

BRD9, IC50: 0.122 μM

++++

CECR2, IC50: 17 nM

{[allProObj[0].p_purity_real_show]}
XMD8-92 ++

BRD4 (1), Kd: 170 nM

{[allProObj[0].p_purity_real_show]}
Mivebresib {[allProObj[0].p_purity_real_show]}
BI-9564 ++++

BRD9, Kd: 5.9 nM

BRD7, Kd: 73 nM

++

CECR2, Kd: 77 nM

{[allProObj[0].p_purity_real_show]}
AZD5153 6-Hydroxy-2-naphthoic acid ++++

FL-BRD4, IC50: 5 nM

{[allProObj[0].p_purity_real_show]}
PLX51107 ++++

BRD4 BD2, Kd: 1.7 nM

BRD3 BD1, Kd: 2.1 nM

{[allProObj[0].p_purity_real_show]}
FL-411 +

BRD4(1), IC50: 0.43 μM

{[allProObj[0].p_purity_real_show]}
ABBV-744 {[allProObj[0].p_purity_real_show]}
dBET6 ++++

BRD4, IC50: 14 nM

{[allProObj[0].p_purity_real_show]}
dBET1 ++++

BRD4, IC50: 20 nM

{[allProObj[0].p_purity_real_show]}
MZ1 ++++

Brd3(BD2), Kd: 13 nM

Brd2(BD2), Kd: 62 nM

{[allProObj[0].p_purity_real_show]}
dBET57 +

BRD4BD1, DC50: 500 nM

{[allProObj[0].p_purity_real_show]}
SF2523 +

BRD4, IC50: 241 nM

DNA-PK {[allProObj[0].p_purity_real_show]}
INCB054329 ++++

BRD3-BD1, IC50: 9 nM

BRD4-BD1, IC50: 119 nM

{[allProObj[0].p_purity_real_show]}
INCB-057643 {[allProObj[0].p_purity_real_show]}
(E/Z)-ZL0420 +++

BRD4 BD1, IC50: 27 nM

BRD4 BD2, IC50: 32 nM

{[allProObj[0].p_purity_real_show]}
BMS-986158 {[allProObj[0].p_purity_real_show]}
BRD4 Inhibitor-10 ++++

BRD4-BD2, IC50: 41 nM

BRD4-BD1, IC50: 5 nM

{[allProObj[0].p_purity_real_show]}
A1874 {[allProObj[0].p_purity_real_show]}
Y06036 ++

BRD4 (1), Kd: 82 nM

{[allProObj[0].p_purity_real_show]}
Alobresib NF-κB {[allProObj[0].p_purity_real_show]}
ODM-207 {[allProObj[0].p_purity_real_show]}
GSK778 +++

BRD2-BD1, IC50: 75nM

BRD4-BD1, IC50: 143 nM

{[allProObj[0].p_purity_real_show]}
SRX3207 +

BRD41, IC50: 3070 nM

BRD42, IC50: 3070 nM

Syk {[allProObj[0].p_purity_real_show]}
GSK046 +++

BRD4BD2, IC50: 214 nM

BRD3BD2, IC50: 98 nM

{[allProObj[0].p_purity_real_show]}
GSK620 {[allProObj[0].p_purity_real_show]}
Thalidomide-NH-C4-NH-Boc {[allProObj[0].p_purity_real_show]}
Trotabresib {[allProObj[0].p_purity_real_show]}
NHWD-870 {[allProObj[0].p_purity_real_show]}
CFT8634 ++++

BRD9, DC50: 3 nM

{[allProObj[0].p_purity_real_show]}
GSK2801 ++

BAZ2B, Kd: 136 nM

BAZ2A, Kd: 257 nM

{[allProObj[0].p_purity_real_show]}
KG-501 {[allProObj[0].p_purity_real_show]}
UNC 669 +

L3MBTL3, IC50: 35 μM

L3MBTL4, IC50: 6 μM

{[allProObj[0].p_purity_real_show]}
PFI-3 +++

SMARCA2A, Kd: 72 nM

SMARCA4, Kd: 55 nM

{[allProObj[0].p_purity_real_show]}
UNC1215 +++

L3MBTL3- D274A, IC50: 3.5 μM

L3MBTL3, IC50: 120 nM

{[allProObj[0].p_purity_real_show]}
EED226 ++

PRC2, Kd: 114 nM

EED, Kd: 82 nM

{[allProObj[0].p_purity_real_show]}
BRD9539 {[allProObj[0].p_purity_real_show]}
UNC926 +

L3MBTL1, Kd: 3.9 μM

{[allProObj[0].p_purity_real_show]}
666-15 ++

CREB, IC50: 81 nM

{[allProObj[0].p_purity_real_show]}
UNC6852 +

EED, IC50: 247 nM

{[allProObj[0].p_purity_real_show]}
BAZ1A-IN-1 +

BAZ1A, Kd: 0.52 μM

{[allProObj[0].p_purity_real_show]}
PFI-4 ++

BRPF2, IC50: 7.9 μM

BRPF1, IC50: 80 nM

{[allProObj[0].p_purity_real_show]}
OF-1 ++

BRPF2, Kd: 500 nM

BRPF1B, Kd: 100 nM

{[allProObj[0].p_purity_real_show]}
GSK-5959 ++

BRPF3, pIC50: 7.1

BRPF2, pIC50: 5.2

{[allProObj[0].p_purity_real_show]}
GSK6853 ++++

BRPF1, pIC50: 8.1

{[allProObj[0].p_purity_real_show]}
NI-42 ++++

BRPF1, IC50: 48 nM

BRPF3, IC50: 260 nM

{[allProObj[0].p_purity_real_show]}
E-7386 +++

CBP/beta-catenin, IC50: 0.0484 μM

{[allProObj[0].p_purity_real_show]}
I-CBP112 ++

p300, Kd: 167 nM

CBP, Kd: 151 nM

{[allProObj[0].p_purity_real_show]}
Histone Acetyltransferase Inhibitor II +

p300, IC50: 5 μM

{[allProObj[0].p_purity_real_show]}
C646 +

p300/CBP, Ki: 400 nM

{[allProObj[0].p_purity_real_show]}
Anacardic Acid +

p300/CBP, IC50: 8.5 μM

PCAF, IC50: 5 μM

{[allProObj[0].p_purity_real_show]}
SGC-CBP30 ++++

EP300, IC50: 38 nM

CREBBP, IC50: 21 nM

{[allProObj[0].p_purity_real_show]}
Nordihydroguaiaretic acid HER2,IGF-1R {[allProObj[0].p_purity_real_show]}
Curcumin +

p300, IC50: ~25 μM

Nrf2,Ferroptosis,NF-κB {[allProObj[0].p_purity_real_show]}
PF-CBP1 HCl ++

p300/CBP, IC50: 363nM

CREBBP, IC50: 125nM

{[allProObj[0].p_purity_real_show]}
CPI-637 +++

EP300, IC50: 0.051 μM

CBP, IC50: 0.03 μM

{[allProObj[0].p_purity_real_show]}
Foscenvivint β-catenin {[allProObj[0].p_purity_real_show]}
A-485 ++

p300 HAT, IC50: 0.06 μM

{[allProObj[0].p_purity_real_show]}
GNE-781 +

BRD4(1), IC50: 5100 nM

++++

CBP, IC50: 0.94 nM

{[allProObj[0].p_purity_real_show]}
NEO2734 +++

BET, IC50: <30 nM

+++

p300/CBP, IC50: <30 nM

{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

MS402 生物活性

描述 MS402 is a BD1-selective BET BrD inhibitor with Kis of 77 nM, 718 nM, 110 nM, 200 nM, 83 nM, and 240 nM for BRD4(BD1), BRD4(BD2), BRD3(BD1), BRD3(BD2), BRD2(BD1), BRD2(BD2), and BRD2(BD2), respectively. MS402 prevents Th17 cell differentiation and ameliorates colitis in mice[1].

MS402 动物研究

Animal study Reconstruction of Rag1-/- mice with naïve CD4+CD45RBhi cells isolated from spleens and lymph nodes of C57BL/6 mice started to decrease body weights after 4 weeks. The weight loss with MS402 (10 mg/kg; intraperitoneal injections twice a week for 3 weeks) showed a much less decrease in body weight[1] .

MS402 参考文献

[1]Cheung K, et al. BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):2952-2957.

MS402 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.70mL

0.54mL

0.27mL

13.48mL

2.70mL

1.35mL

26.97mL

5.39mL

2.70mL

MS402 技术信息

CAS号1672684-68-2
分子式C20H19ClN2O3
分子量 370.829
别名
运输蓝冰
存储条件

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 105 mg/mL(283.15 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。